Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

April 28, 2020

Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).

Ewa Wajs , Leah Aluisio , Richard Holder , et al

Original Research

Bridging the Gap Between Mixed and Atypical Depression

February 19, 2019

Is there a common denominator between mixed depression and atypical depressive features? In this post hoc analysis of the BRIDGE-II-MIX Study, affective lability and mood reactivity were investigated in...

Norma Verdolini , Giulia Menculini , Giulio Perugi , et al

Original Research

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

March 25, 2015

Giulio Perugi , Jules Angst , Jean-Michel Azorin , et al

Original Research

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

March 9, 2010

Ric M. Procyshyn , William G. Honer , Tony K. Y. Wu , et al

Original Research

Quetiapine vs Lithium for Bipolar

January 26, 2010

Read a study comparing the efficacy and tolerability of quetiapine and lithium monotherapy with a placebo for a major depressive episode in bipolar disorder.

Allan H. Young , Susan L. McElroy , Michael Bauer , et al

Original Research

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

January 26, 2010

Susan L. McElroy , Richard H. Weisler , William Chang , et al

Educational Activity

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

August 15, 2009

Allan H. Young

Academic Highlights

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

October 31, 2008

Siegfried Kasper , Joseph R. Calabrese , Gordon Johnson , et al

Article

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

June 15, 2007

Allan H. Young

Educational Activity

The Art and Science of Switching of Antipsychotic Medications, Part 1

November 15, 2006

Peter J. Weiden , Allan H. Young , Peter F. Buckley

Letter to the Editor

Dr. Macking and Young Reply

May 15, 2006

Paul Mackin , Allan H. Young

Original Research

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

November 15, 2005

Paul Mackin , Allan H. Young

Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

Bridging the Gap Between Mixed and Atypical Depression

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

The Art and Science of Switching of Antipsychotic Medications, Part 1

Dr. Macking and Young Reply

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

ELSEWHERE:

FOLLOW US:

Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

Bridging the Gap Between Mixed and Atypical Depression

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

The Art and Science of Switching of Antipsychotic Medications, Part 1

Dr. Macking and Young Reply

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles